Innovative AI Platform QuantHealth’s AI-driven platform offers advanced patient response predictions and trial optimization, presenting an opportunity to target pharmaceutical companies seeking to enhance clinical trial success rates and reduce time-to-market.

High-value Data Assets With one of the largest integrated datasets in the biotech industry, QuantHealth provides valuable insights that can be leveraged by research organizations and biotech firms looking to improve their drug discovery processes.

Market Potential Operating in a sector with substantial direct losses due to clinical trial failures (over 45 billion dollars annually), there is a significant demand for solutions that mitigate these risks, positioning QuantHealth as a strategic partner.

Growth Opportunity The company's revenue range of 10 to 25 million dollars indicates an expanding client base, offering sales teams avenues to target emerging biotech and pharma firms seeking innovative trial solutions.

Strategic Location Based in Tel Aviv, a major biotech hub, QuantHealth is well-placed to collaborate with local and international biotech startups and established pharmaceutical companies aiming to digitize and optimize clinical development.